A Phase IIa randomized, double-blind, placebo-controlled clinical trial comparing the efficacy and safety of ZYN001 with placebo in fibromyalgia and peripheral neuropathic pain
Phase of Trial: Phase II
Latest Information Update: 14 Nov 2017
At a glance
- Drugs ZYN 001 (Primary)
- Indications Fibromyalgia; Neuropathic pain
- Focus Therapeutic Use
- 14 Nov 2017 According to a Zynerba Pharmaceuticals media release, this trial is expected to initiate in 2018.
- 01 Aug 2017 Planned initiation date changed from 1 Jul 2017 to 1 Dec 2017, according to a Zynerba Pharmaceuticals media release.
- 09 May 2017 Planned initiation date changed from 1 Jan 2017 to 1 Jul 2017,according to a Zynerba Pharmaceuticals media release.